Recent Advances in Mass Spectrometry-Based Glycomic and Glycoproteomic Studies of Pancreatic Diseases
Modification of proteins by glycans plays a crucial role in mediating biological functions in both healthy and diseased states. Mass spectrometry (MS) has emerged as the most powerful tool for glycomic and glycoproteomic analyses advancing knowledge of many diseases. Such diseases include those of t...
Main Authors: | Dylan Nicholas Tabang, Megan Ford, Lingjun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fchem.2021.707387/full |
Similar Items
-
Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer
by: Randa G. Hanna-Sawires, et al.
Published: (2021-03-01) -
Mass Spectrometry Imaging for Glycome in the Brain
by: Md. Mahmudul Hasan, et al.
Published: (2021-07-01) -
Application of Mass Spectrometry in Pancreatic Cancer Translational Research
by: Peng Ge, et al.
Published: (2021-10-01) -
Proteomic Investigation of Glyceraldehyde-Derived Intracellular AGEs and Their Potential Influence on Pancreatic Ductal Cells
by: Lakmini Senavirathna, et al.
Published: (2021-04-01) -
An Integrated Mass Spectrometry-Based Glycomics-Driven Glycoproteomics Analytical Platform to Functionally Characterize Glycosylation Inhibitors
by: Michael Russelle S. Alvarez, et al.
Published: (2022-06-01)